Fluoxetine Attenuates Chronic Methamphetamine-induced Pulmonary Arterial Remodelling: Possible Involvement of Serotonin Transporter and Serotonin 1B Receptor

Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats

(2011) Xue-qin Li et al.   ACTA PHARMACOLOGICA SINICA

Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling

(2011) Yun Wang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Role of the Serotonergic System in Reduced Pulmonary Function after Exposure to Methamphetamine

(2009) Sandra M. Wells et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Serotonin (5-HT) Transporter Ligands Affect Plasma 5-HT in Rats

(2009) Richard B. Rothman et al.   Annals of the New York Academy of Sciences

In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension

(2009) I. Morecroft et al.   CARDIOVASCULAR RESEARCH

FLUOXETINE PROTECTS AGAINST MONOCROTALINE-INDUCED PULMONARY ARTERIAL HYPERTENSION: POTENTIAL ROLES OF INDUCTION OF APOPTOSIS AND UPREGULATION OF Kv1.5 CHANNELS IN RATS

(2009) Feng-Guo Zhai et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Serotonin and pulmonary hypertension—from bench to bedside?

(2009) Margaret R MacLean et al.   CURRENT OPINION IN PHARMACOLOGY

Pulmonary arterial hypertension seen in methamphetamine abusers

(2008) Cheryl A. Thompson   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Pharmacologic mechanisms of crystal meth

(2008) S. J. Kish   CANADIAN MEDICAL ASSOCIATION JOURNAL

Acute Inhalation Exposure to Vaporized Methamphetamine Causes Lung Injury in Mice

(2008) Sandra M. Wells et al.   INHALATION TOXICOLOGY

Brain serotonin transporter in human methamphetamine users

(2008) Stephen J. Kish et al.   PSYCHOPHARMACOLOGY